Prevnar 13/Prevenar 13 is Pfizer vaccines for prevention of pneumococcal disease. In 2014, the Advisory Committee on Immunization Practices (ACIP) voted to recommend Prevnar 13 for routine use to help protect adults aged 65 years and older against pneumococcal disease, which for adults includes pneumonia caused by the 13 pneumococcal serotypes included in the vaccine. MNG Tracker report title “Prevnar 13/Prevenar 13 Vaccine Sales & Forecast” provides historical as well as estimated Prevnar 13/Prevenar 13 sales in Global, United States and Rest of the World market. This is single page report which also covered key factors for the growth/decline of the Prevnar 13/Prevenar 13 sales in Global, United States and Rest of the World market.
MNG Tracker is a market research company which offer market research reports and database subscription service. Continuous tracking on latest changes in the industry and predict about the emerging needs, challenges and opportunities, is the essential needs for the growth of the business. MNG Tracker is exists for that. MNG Tracker is steadily monitored on the latest happening in the industries, companies and regulatory policies around the world. MNG Tracker is all about market, research and data. We know our clients; who they are, what they see and what they do. MNG Tracker team is fully dedicated to achieve their needs and expectation.
125/5D, Sector 5 Vrindavan Yojna,
Lucknow - 226002, India
Phone:+91 8527886312,
+ 91 7530849871
Email: info@mngtracker.com
FOLLOW USCOPYRIGHT © 2018 MNG Tracker. All Rights Reserved.